A New Prescription

In this episode, Dr. Leonard Zwelling speaks with Dr. Tim Connolly of Houston Methodist Hospital and Texas A&M EnMed School of Medicine about obstructive sleep apnea—a common but often overlooked condition that affects breathing during sleep. They discuss how sleep apnea develops, why it is frequently first noticed by bed partners, and how it can impact overall health if left untreated. The co...

While modern technology has transformed diagnosis and treatment, Dr. Lipman argues it has come at a cost—the loss of time, trust, and true doctor-patient relationships. The conversation explores physician burnout, corporatized healthcare, hospitalists, EMRs, concierge medicine, and the role AI could play in restoring—or further eroding—human care.

In this episode of A New Prescription , Dr. Leonard and Andrew Zwelling talk with Duke professor Dr. Cameron McIntyre about deep brain stimulation (DBS) — how it works, its success in treating conditions like Parkinson’s, epilepsy, and OCD, and new research into depression and PTSD. They also explore the future of brain-machine interfaces, the ethics of neural enhancement, and what this technology...

Dr. Leonard Zwelling and Andrew talk with Dr. José Banchs about how primary care doctors screen for heart disease before symptoms appear. They cover blood pressure, EKGs, imaging tests, sleep apnea links, and new innovations like microbubble imaging—all aimed at keeping your heart healthy.

In this episode of A New Prescription , Dr. Leonard Zwelling, Andrew, and cardiologist Dr. Susan Gilchrist unpack how to assess and prevent cardiovascular disease—covering risk calculators, cholesterol, fitness, and when lifestyle changes or medication matter most.

In this episode of A New Prescription , we talk with Dr. Theresa Bevers of MD Anderson about the pillars of cancer prevention, the latest screening guidelines, and how lifestyle and genetics shape risk. A practical, insightful look at what you can do today to lower your chances of cancer and catch it early.

Discover how acupuncture is bridging Eastern and Western medicine in this eye-opening episode with Dr. Dimitri Papadopoulos, a Western-trained physician turned acupuncturist. From chronic pain to PTSD and cancer support, we explore its surprising benefits and scientific backing.

Join us for an insider’s look at the FDA, the National Cancer Institute, and modern healthcare leadership with Dr. Andrew von Eschenbach — former FDA Commissioner and a pioneer in cancer research. Discover how collaboration, culture, and bold thinking shape the treatments that reach patients today.

Most healthcare waits until you’re sick — but what if you could see problems coming? Learn how DNA testing, biomarker tracking, and simple daily habits can help you outsmart disease before it starts.

In this episode, we dive deep into the science, social constructs, and political controversies surrounding sex and gender. Our guest guest Neha Verdi, MD/PhD candidate, unpacks the critical differences between sex and gender, how this impacts health care. This is an insightful conversation that brings clarity to a complex topic.

In this episode, Dr. Phillipp Rauschendorfer joins us to explore a revolutionary new catheter designed to transform how we diagnose and treat coronary artery disease. We unpack the science behind this dual-imaging device, its journey from lab to preclinical testing, and the complex path toward FDA approval. From NIH funding to the 510(k) process, this episode offers an inside look at what it reall...

In this episode of A New Prescription , we go deep into the origins, mission, and modern challenges of the CDC with Dr. Stephen C. Redd — former CDC leader and incident commander during the H1N1 pandemic. We explore the agency’s role in public health, its decline in public trust, vaccine skepticism, and whether America is truly prepared for the next pandemic.

In this episode of A New Prescription, we explore the transformative role of exercise in cancer treatment with Dr. Savannah Rauschendor discussing how prehabilitation improves patient outcomes. We also delve into RFK's efforts to close the FDA's GRAS loophole for food safety and examine the impact of Trump's tariffs on healthcare costs.

We dive into the hype surrounding GLP-1 and GIP weight loss drugs like Ozempic, Wegovy and Mounjaro. With commercials and social media buzzing about these medications, we ask the important questions: Do they really work long-term? Who should be taking them? And what are the potential risks? Joining us is Dr. Efstratios Koutroumpakis, Assistant Professor of Medicine at MD Anderson Cancer Center, to...

In this episode, we're joined by Scott Wham , Director of Compliance and Innovation at OneDigital , to explore the intricate and ever-shifting landscape of American healthcare policy. Comparing it to the world's most complicated game of Jenga, we’ll discuss how one wrong move—whether from policymakers, insurers, or employers—could send the entire system crashing down.

In this episode, Andrew Zwelling and Dr. Leonard Zwelling discuss the controversy surrounding RFK Jr.'s nomination as Secretary of Health and Human Services. They examine his views on vaccines, public health policies, and what his leadership could mean for the future of healthcare in the U.S. As the conversation shifts from national health policy to the realities faced by doctors on the ground, Dr...

In this episode of A New Prescription , Andrew and Dr. Leonard Zwelling explore what it takes to be a truly effective patient in today's fast-paced healthcare system. They discuss the importance of clear communication, advocating for yourself, and working with your doctor to achieve accurate diagnoses and effective treatment plans. Using real-life examples, including Andrew's wife's sinus infectio...

In this inaugural episode of A New Prescription , hosts Andrew and Dr. Leonard A. Zwelling dive into a pressing issue in today’s healthcare system: the lack of time doctors have to truly connect with and examine their patients. Dr. Zwelling shares his personal experiences, revealing the dangers of rushed consultations, and explores how corporate-driven healthcare and insurance companies contribute...